Unknown

Dataset Information

0

Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Tarlock K 

PROVIDER: S-EPMC7193184 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia.

Tarlock Katherine K   Alonzo Todd T   Wang Yi-Cheng YC   Gerbing Robert B RB   Ries Rhonda E RE   Hylkema Tiffany T   Smith Jenny L JL   Maxson Julia E JE   Meshinchi Soheil S  

Blood 20200401 18

Similar Datasets

Unknown CSF3R Mutations Imply Adverse Prognostic Impact in Adult Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study.
| S-EPMC12719048 | biostudies-literature
Unknown RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development.
| S-EPMC10544281 | biostudies-literature
Unknown Prognostic impact of <i>IL7R</i> mutations on acute myeloid leukemia.
| S-EPMC11439168 | biostudies-literature
Unknown Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia.
| S-EPMC11063409 | biostudies-literature
Unknown DNMT3A mutations are rare in childhood acute myeloid leukemia.
| S-EPMC3148921 | biostudies-literature
Unknown Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.
| S-EPMC6884457 | biostudies-literature
Unknown Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia.
| S-EPMC5070622 | biostudies-literature
Unknown Incidence and prognostic impact of DNMT3A mutations in Korean normal karyotype acute myeloid leukemia patients.
| S-EPMC4306257 | biostudies-literature
Unknown Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia.
| S-EPMC11551470 | biostudies-literature
Unknown Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations.
| S-EPMC8427751 | biostudies-literature